SBC Medical Group (SBC) Expected to Announce Earnings on Thursday

SBC Medical Group (NASDAQ:SBC) is projected to announce its Q2 2026 results before the market opens on Thursday, August 13th. Analysts expect the company to announce earnings of $0.12 per share and revenue of $45.3710 million for the quarter. Parties can find conference call details on the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Thursday, August 13, 2026 at 8:30 AM ET.

SBC Medical Group (NASDAQ:SBC) last posted its earnings results on Thursday, May 14th. The company reported $0.11 EPS for the quarter, topping analysts’ consensus estimates of $0.10 by $0.01. The firm had revenue of $43.06 million during the quarter, compared to analysts’ expectations of $41.66 million. SBC Medical Group had a net margin of 24.09% and a return on equity of 15.90%. On average, analysts expect SBC Medical Group to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

SBC Medical Group Trading Up 3.9%

Shares of SBC Medical Group stock opened at $3.20 on Wednesday. The firm’s 50 day moving average is $3.06 and its 200 day moving average is $3.58. The firm has a market capitalization of $328.26 million, a PE ratio of 8.21 and a beta of 0.59. SBC Medical Group has a 1 year low of $2.78 and a 1 year high of $5.07. The company has a current ratio of 3.82, a quick ratio of 3.78 and a debt-to-equity ratio of 0.12.

Institutional Trading of SBC Medical Group

A number of large investors have recently bought and sold shares of SBC. Geode Capital Management LLC bought a new stake in shares of SBC Medical Group during the second quarter valued at approximately $455,000. XTX Topco Ltd acquired a new stake in SBC Medical Group in the 2nd quarter valued at $64,000. New York State Common Retirement Fund acquired a new stake in SBC Medical Group in the 2nd quarter valued at $104,000. Millennium Management LLC bought a new stake in SBC Medical Group during the 3rd quarter valued at $219,000. Finally, Goldman Sachs Group Inc. bought a new stake in SBC Medical Group during the 4th quarter valued at $49,000. 60.82% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research firms have weighed in on SBC. Wall Street Zen raised shares of SBC Medical Group to a “hold” rating in a research note on Saturday, May 9th. Weiss Ratings cut SBC Medical Group from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Friday, May 22nd. Two investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, SBC Medical Group has an average rating of “Hold” and a consensus target price of $8.50.

SBC Medical Group Company Profile

SBC Medical Group, Inc is a publicly traded healthcare management services company listed on the Nasdaq under the ticker SBC. The company specializes in supporting in-office ancillary service providers by offering a suite of administrative and operational solutions designed to streamline practice management and enhance revenue performance. Its core mission is to help physician practices, imaging centers and other ancillary service providers focus on patient care while outsourcing complex back-office functions.

The company’s primary offerings include revenue cycle management, medical billing and coding, compliance oversight and transcription services.